DE69116582D1 - Verfahren zur Herstellung von rekombinantem Humaninterferon-beta in reiner Form - Google Patents

Verfahren zur Herstellung von rekombinantem Humaninterferon-beta in reiner Form

Info

Publication number
DE69116582D1
DE69116582D1 DE69116582T DE69116582T DE69116582D1 DE 69116582 D1 DE69116582 D1 DE 69116582D1 DE 69116582 T DE69116582 T DE 69116582T DE 69116582 T DE69116582 T DE 69116582T DE 69116582 D1 DE69116582 D1 DE 69116582D1
Authority
DE
Germany
Prior art keywords
recombinant human
interferon
human beta
production
eluted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69116582T
Other languages
English (en)
Inventor
Otello Protasi
Paolo Rappuoli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sclavo SpA
Original Assignee
Sclavo SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sclavo SpA filed Critical Sclavo SpA
Application granted granted Critical
Publication of DE69116582D1 publication Critical patent/DE69116582D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69116582T 1990-03-16 1991-03-12 Verfahren zur Herstellung von rekombinantem Humaninterferon-beta in reiner Form Expired - Lifetime DE69116582D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19699A IT1240612B (it) 1990-03-16 1990-03-16 Procedimento di purificazione del b-interferone umano ricombinante

Publications (1)

Publication Number Publication Date
DE69116582D1 true DE69116582D1 (de) 1996-03-07

Family

ID=11160484

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69116582T Expired - Lifetime DE69116582D1 (de) 1990-03-16 1991-03-12 Verfahren zur Herstellung von rekombinantem Humaninterferon-beta in reiner Form

Country Status (6)

Country Link
EP (1) EP0446850B1 (de)
JP (1) JPH0568583A (de)
KR (1) KR910016928A (de)
AT (1) ATE133421T1 (de)
DE (1) DE69116582D1 (de)
IT (1) IT1240612B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0551535A1 (de) * 1992-01-13 1993-07-21 SCLAVO S.p.A. Verfahren zur Reinigung von rekombinant-menschlichem Interferon-Beta, dadurch gereinigtes Interferon-Beta und pharmazeutische Zusammensetzungen, die diese enthalten
KR100524872B1 (ko) 2003-12-04 2005-11-01 씨제이 주식회사 인터페론 베타의 정제방법
DE102009032179A1 (de) 2009-07-07 2011-01-13 Biogenerix Ag Verfahren zur Reinigung von Interferon beta

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL67896A (en) * 1983-02-13 1987-03-31 Yeda Res & Dev Two biologically active human gama interferon subtypes,purification thereof and pharmaceutical compositions containing them
US4908432A (en) * 1987-01-09 1990-03-13 New York University Novel polypeptide having gamma-interferon activity
IT1222427B (it) * 1987-07-31 1990-09-05 Sclavo Spa Procedimento per la purificazione di interferone

Also Published As

Publication number Publication date
IT9019699A0 (it) 1990-03-16
ATE133421T1 (de) 1996-02-15
EP0446850B1 (de) 1996-01-24
EP0446850A2 (de) 1991-09-18
EP0446850A3 (de) 1991-11-06
KR910016928A (ko) 1991-11-05
JPH0568583A (ja) 1993-03-23
IT9019699A1 (it) 1991-09-16
IT1240612B (it) 1993-12-17

Similar Documents

Publication Publication Date Title
BR8301918A (pt) Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase
DE69328519D1 (de) Chondroitinase, Herstellungsverfahren und pharmazeutische Zusammensetzung
DK0447585T4 (da) Fremgangsmåde til fremstilling af et intravenøst tolerant immunglobulin-G-præparat
PT813541E (pt) Processo de producao de uma proteina
FI103506B1 (fi) Menetelmä syklisten aminohappojohdannaisten valmistamiseksi ja menetelmässä käytettävä välituote
PT100988A (pt) Processo para a purificacao de anticorpos
ES2035920T3 (es) Aerolizacion de agente proteico terapeutico.
ES525361A0 (es) Procedimiento para preparar un medicamento seguro contra hepatitis que contiene la proteina llamada inactivador cl.
FI902017A0 (fi) Foerfarande foer rengoering av protein.
ES8407499A1 (es) Un metodo para la obtencion de interferon inmune humano homogeneo de pureza aumentada.
SE8005498L (sv) Homogent fibroblastinterferon och framstellning derav
DE69024105D1 (de) Verfahren zur Herstellung von gereinigten Albuminlösungen
DE69116582D1 (de) Verfahren zur Herstellung von rekombinantem Humaninterferon-beta in reiner Form
DE58907555D1 (de) Verfahren zur Anreicherung der Blutgerinnungsfaktoren II, VII, IX und X.
ATE522617T1 (de) Verfahren zur aufreinigung von interferon-beta
GB941019A (en) Improvements in and relating to the stability of anti-haemophilic globulin (factor viii)
ATE215599T1 (de) Superoxid dismutase-4
ATE136552T1 (de) Reinigung von menschlichem, aus einer escherichia coli mutante abgesonderten interleukin 4
ATE37873T1 (de) Verfahren zur herstellung optisch aktiver 1,4dihydropyridine.
DE69606959D1 (de) Verfahren zur Herstellung von Plättchen-Faktor-4
ES2068392T3 (es) Procedimiento de purificacion de interferon.
PT73587B (en) Process for preparing novel peptides
DK547486A (da) Peptider samt praeparater indeholdende disse
JPS54138189A (en) Separation and purification of urokinase
IT1163940B (it) Processo perfezionato per la preparazione di alfaamminoacidi da amidocianoacetati

Legal Events

Date Code Title Description
8332 No legal effect for de